Company Filing History:
Years Active: 2014
Title: Konrad Herrmann: Innovator in Pharmaceutical Chemistry
Introduction
Konrad Herrmann is a notable inventor based in Grimma, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the treatment of non-solid malignant tumors. His innovative work has the potential to impact the lives of many patients suffering from hematological malignancies.
Latest Patents
Herrmann holds a patent for "Substituted 5H-pyrimido[5,4-B]indoles, method for the production thereof and use thereof for treating non-solid malignant tumors of the blood-producing system." This invention relates to compounds that can induce apoptosis in leukemic B lymphocytes, providing a promising avenue for treating leukemias and lymphomas. The patent highlights the processes for producing these compounds and their pharmaceutical applications.
Career Highlights
Throughout his career, Herrmann has worked with reputable organizations, including The Medicines Company and The Medicines Company (Leipzig) GmbH. His experience in these companies has allowed him to develop and refine his innovative ideas in pharmaceutical research.
Collaborations
Some of his notable coworkers include Claudia Reichelt and Alexander Schulze. Their collaboration has contributed to the advancement of research in the field of oncology.
Conclusion
Konrad Herrmann's work exemplifies the intersection of innovation and healthcare, showcasing the importance of research in developing new treatments for serious medical conditions. His contributions to pharmaceutical chemistry are noteworthy and have the potential to make a significant impact in the medical field.